Table 4 Multivariable analysis before and after PSM for multiple-Sedative Group
Before PSM | After PSM | |||||
|---|---|---|---|---|---|---|
Dex + Pro vs. Dex + Mid | Pro + Mid vs. Dex + Mid | Pro + Mid vs. Dex + Pro | Dex + Pro vs. Dex + Mid | Pro + Mid vs. Dex + Mid | Pro + Mid vs. Dex + Pro | |
Hospital mortality a | 0.56 (0.26–1.26),0.155 | 1.35 (0.66–2.93),0.411 | 2.40 (1.50–3.89), < 0.001 | 0.62 (0.26–1.61),0.252 | 1.62 (0.70–4.12),0.263 | 2.62 (1.59–4.37), < 0.001 |
Dialysis Proportion a | 2.14 (1.04–4.73),0.038 | 1.44 (0.69–3.20),0.40 | 0.67 (0.45-1.00),0.042 | 2.57 (1.10–6.73),0.021 | 1.66 (0.69–4.43),0.252 | 0.65 (0.42-1.00),0.039 |
MV Proportion a | 1.78 (0.17–11.28),0.617 | 1.52 (0.15–8.82),0.640 | 0.85 (0.20–3.40),1.000 | 2.29 (0.21–14.59),0.288 | 1.87 (0.17–11.95),0.612 | 0.82 (0.19–3.61),0.760 |
Norepinephrine Proportion a | 1.02 (0.51–1.98)1.000 | 1.25 (0.62–2.45)0.509 | 1.23 (0.82–1.86)0.320 | 1.14 (0.53–2.38)0.723 | 1.23 (0.56–2.62)0.585 | 1.08 (0.70–1.67)0.754 |
ICU_ Duration b | -1.17(-4.18-1.84),0.632 | -1.05(-4.05-1.95),0.691 | 0.12(-1.70-1.94),0.987 | -3.04(-6.40-0.33),0.087 | -3.11(-6.53-0.31),0.083 | -0.07(-2.03-1.88),0.996 |
Hospital Duration b | 0.12(-6.22-6.45),0.999 | -0.58(-6.90-5.73),0.974 | -0.70(-4.53-3.13),0.903 | -2.27(-7.57-3.03),0.572 | -4.57(-9.95-0.81),0.114 | -2.30(-5.37-0.78),0.185 |